Abstract
Biotechnology mergers and acquisitions are gaining momentum, but may not always lead to a financial windfall.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
114,72 €
only 9,56 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
McCafferty, J. April 1998. CFO 44–52.
Persidis, A. 1998. Nat. Biotechnol. 16: 981– 983.
Hamilton, J.O.C. 1998. Recombinant Capital. http://www.recap.com.
James, B.G. 1998. Decision Resources, PharmVision 2005.
Champsi, F.H. 1998. Nat. Biotechnol. (Bioentrepre-neurship Suppl.)16: 61–62.
Esposito, R.S. and Ostro, M.J. 1998. Nat. Biotechnol. (Bioentrepreneurship Suppl.) 16: 63.
Bernstein K. et al.1998.BioCentury 6/54: A1–A6.
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Persidis, A. Consolidations in biotechnology. Nat Biotechnol 17, BE3–BE4 (1999). https://doi.org/10.1038/4624
Issue Date:
DOI: https://doi.org/10.1038/4624